Data-Driven Drug Development: Accelerating Small Molecule Success in Early Phase

The development of small-molecule therapeutics has never been more complex. Pharmaceutical researchers are faced with molecules with higher molecular weight and increasing 3D character. At the same time, regulatory expectations are rising, market competition is intensifying, and patient needs demand more rapid development timelines. In this context, leveraging early-phase, data-driven strategies is essential for accelerating drug development while mitigating risk.

LATEST VIDEO

Latest news

19th November 2025

Novartis announces plans to build flagship manufacturing hub in North Carolina

19th November 2025

Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates

19th November 2025

Inizio Evoke launches Predictev™, a query-driven predictive intelligence engine for life-sciences commercial teams

17th November 2025

Johnson & Johnson to Acquire Halda Therapeutics for $3.05 Billion

17th November 2025

First Pertzumab Biosimilar Receives FDA Approval

17th November 2025

Almac announces multi-million-pound investment in Singapore

14th November 2025

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal

14th November 2025

FDA Approves Acute Myeloid Leukemia Treatment

14th November 2025

Bristol Myers Squibb and Sarah Cannon Research Institute Announce Clinical Trial Collaboration

13th November 2025

General Proximity Announces Multi-Target Oncology Collaboration with Daiichi Sankyo

13th November 2025

BostonGene and Kyoto University Enter Precision Drug Development Collaboration

This week’s featured articles

CDMO Partnerships Built on Flexibility, Innovation, Strategic Investment, Sustainability & True End-to-End Support

Large Language Models and Beyond: AI’s Impact on Clinical Trial Efficiency and Integrity

Innovation in mAb purification using affinity chromatography resins based on proprietary rProtein A

Unpacking Global Biopharma Business Relations with Ashu Tandon

A surprising comparison between CDMOs and auto makers

Partnered with top industry events and organisations